Star Health and Allied Insurance Company Ltd

Star Health and Allied Insurance Company Limited reported a 16% Year-on-Year (YoY) increase in Profit After Tax (PAT) to ₹911 Crores for FY26. The company's Gross Written Premium (GWP) grew 16% YoY to ₹20,369 Crores, with retail health premium increasing 20% to ₹19,341 Crores, maintaining a 31% market share. A significant improvement was seen in the Combined Ratio, which bettered to 98.8% in FY26 from 101.1% in FY25, driven by a moderation in loss ratio to 68.7% and an improved expense ratio to 30.1%. The company also achieved an underwriting profit of ₹206 Crores, reversing a loss of ₹165 Crores in FY25. Q4 FY26 performance also showed strong growth with GWP up 17% and a Combined Ratio of 95.7%. Star Health settled approximately 30 lakh claims amounting to over ₹11,900 Crores and maintained a 99% persistency rate, while digital channels contributed significantly to fresh retail sales.

Star Health and Allied Insurance Company Limited has submitted its audited financial results for the quarter and financial year ended March 31, 2026. The filing is in compliance with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 and related BSE/NSE circulars. The financial statements, which form the basis of these results, were approved by the Company's Board of Directors in their meeting held on April 28, 2026. The independent auditors, MSKA&AssociatesLLP and T R Chadha & Co LLP, have issued an opinion stating that the results are presented in accordance with SEBI Listing Regulations and IRDAI circulars, and provide a true and fair view of the net profit and other financial information.

Star Health and Allied Insurance Company Ltd's Board of Directors, at their meeting on April 28, 2026, approved the Audited Standalone financial results for the quarter and financial year ended March 31, 2026. The results were accompanied by an Independent Auditors Report from M/s. T R Chadha & Co LLP and M/s. MSKA & Associates, which expressed an unmodified opinion. The company also provided required disclosures under SEBI Listing Regulations, including a declaration on the unmodified audit opinion and supplementary financial information prepared under Ind AS (IFRS). The meeting commenced at 11:30 A.M. and concluded at 04:40 P.M. The information is also hosted on the company's website.

Star Health and Allied Insurance Company Ltd announced the declaration of its standalone audited financial results for the quarter and financial year ended March 31, 2026. The Board of Directors approved these results at their meeting held on April 28, 2026. The filing includes the Audited Standalone Financial Results along with the Independent Auditors Report issued by M/s. T R Chadha & Co LLP and M/s. MSKA & Associates, the Joint Statutory Auditors. Additionally, disclosures required under Regulation 52(4) and a declaration on the unmodified audit opinion in accordance with Regulation 33(3)(d) and 52(3)(a) of SEBI Listing Regulations were enclosed. Audited financial information prepared under Ind AS (IFRS) was also provided as supplementary information.

Star Health and Allied Insurance Company Limited has received no-objection from both BSE Limited and National Stock Exchange of India Limited for the reclassification of two entities, Ebano Private Limited and GS E-Commerce Private Limited. These entities will be reclassified from the 'Promoter/Promoter Group category' to the 'Public category' in accordance with Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company had submitted its application for this reclassification on January 30, 2026, and received the approvals on April 27, 2026. Star Health will ensure compliance with all subsequent relevant disclosures as required by the Listing Regulations.

Star Health and Allied Insurance Company Limited has received approval from the Insurance Regulatory and Development Authority of India (IRDAI) for the proposed transmission of 8,28,82,958 equity shares held by Late Mr. Rakesh Jhunjhunwala in the Company. The transmission will be carried out in accordance with the probate granted in the name of Late Mr. Rakesh Jhunjhunwala.

Star Health And Allied Insurance Company Ltd. has informed the BSE that the meeting of the Board of Directors is scheduled on 28/04/2026. The meeting will inter alia consider and approve the standalone audited financial results of the Company for the financial year ended March 31, 2026. This disclosure is in compliance with Regulation 29(1) (a) and 50(1) (c) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended.

Star Health and Allied Insurance Company Limited has informed the Exchange about the closure of the trading window for designated persons/insiders, including their immediate relatives. The closure is in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's Policy on Insider Trading. The trading window will remain closed from Thursday, April 01, 2026, till the completion of 48 hours after the declaration of audited financial results for the quarter and financial year ended March 31, 2026. The date of the Board Meeting for the declaration of audited financial results will be intimated in due course.

Star Health and Allied Insurance Company Limited has informed the exchange about the appointment of Mr. Himanshu Walia and Mr. Amitabh Jain as Whole-time Directors and Key Managerial Personnel. The appointments are for a period of five years with effect from February 11, 2026, following the approval by the IRDAI and the Board of Directors and Shareholders. Both appointees are experienced professionals in the insurance industry, with Mr. Walia serving as Chief Marketing Officer at Star Health and Mr. Jain being a founding member of ICICI Lombard and serving as Chief Operating Officer at Star Health.

ICICI Prudential Mutual Fund has sold 15,07,850 shares of Star Health and Allied Insurance Company Ltd. on January 29, 2026, decreasing its shareholding by more than 2% compared to the previous disclosure on May 05, 2025. The Fund under its schemes has carried out net sale of 1,22,29,062 shares of the Company from the last filing submitted on May 05, 2025. The holding by schemes of the Fund is from an investment perspective and not with the objective of seeking any controlling interest.